475 related articles for article (PubMed ID: 28704198)
1. Alzheimer's disease: as it was in the beginning.
Kozlov S; Afonin A; Evsyukov I; Bondarenko A
Rev Neurosci; 2017 Nov; 28(8):825-843. PubMed ID: 28704198
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tau Protein on Mitochondrial Functions.
Epremyan KK; Goleva TN; Zvyagilskaya RA
Biochemistry (Mosc); 2022 Aug; 87(8):689-701. PubMed ID: 36171651
[TBL] [Abstract][Full Text] [Related]
4. [THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE].
Szarka A
Ideggyogy Sz; 2015 Jul; 68(7-8):222-8. PubMed ID: 26380416
[TBL] [Abstract][Full Text] [Related]
5. A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
Atwood CS; Bowen RL
J Alzheimers Dis; 2015; 47(1):33-47. PubMed ID: 26402752
[TBL] [Abstract][Full Text] [Related]
6. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
VanItallie TB
Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.
Esteras N; Abramov AY
Cells; 2020 Sep; 9(9):. PubMed ID: 32967303
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease.
Silva DF; Esteves AR; Oliveira CR; Cardoso SM
Curr Alzheimer Res; 2011 Aug; 8(5):563-72. PubMed ID: 21244356
[TBL] [Abstract][Full Text] [Related]
12. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
13. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
Pamphlett R; Kum Jew S
J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
[TBL] [Abstract][Full Text] [Related]
14. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
[TBL] [Abstract][Full Text] [Related]
15. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
[TBL] [Abstract][Full Text] [Related]
16. A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.
Han P; Shi J
J Alzheimers Dis; 2016 Apr; 52(4):1461-70. PubMed ID: 27104897
[TBL] [Abstract][Full Text] [Related]
17. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
Butterfield DA; Perluigi M; Sultana R
Eur J Pharmacol; 2006 Sep; 545(1):39-50. PubMed ID: 16860790
[TBL] [Abstract][Full Text] [Related]
19. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
Crouch PJ; White AR; Bush AI
FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
[TBL] [Abstract][Full Text] [Related]
20. Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis.
Soler-López M; Badiola N; Zanzoni A; Aloy P
Bioessays; 2012 Jul; 34(7):532-41. PubMed ID: 22513506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
